Evidence map›Paper›PMID 42449679›Full record

ArticleCancers2026

Neoadjuvant Immunotherapy for Hepatocellular Carcinoma Is Associated with Improved Survival After Hepatectomy: A Matched Analysis of the 2017 to 2022 National Cancer Database.

Lawrence Chiang, Adam Bodzin, Daniel Lin, Nader Hanna, Scott Koeneman, Hien Dang, Charles J Yeo, Christopher Shubert, Richard Zheng

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lawrence ChiangDepartment of Surgery, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.
Adam BodzinDepartment of Surgery, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.ORCID 0000-0001-6255-2087
Daniel LinDepartment of Medicine, Division of Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.ORCID 0000-0003-1352-8915
Nader HannaDepartment of Surgery, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.
Scott KoenemanDepartment of Surgery, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.
Hien DangDepartment of Surgery, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.ORCID 0000-0003-2446-3985
Charles J YeoDepartment of Surgery, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.ORCID 0000-0001-8097-0071
Christopher ShubertDepartment of Surgery, Division of Surgical Oncology, Johns Hopkins Hospital, Johns Hopkins University, Baltimore, MD 21287, USA.ORCID 0000-0001-6472-2350
Richard ZhengDepartment of Surgery, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

hepatocellular carcinomaNational Cancer Databaseneoadjuvant immunotherapy

Identifiers

PMID42449679
PMCPMC13360380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.